SG11202003873WA - Population-based medication risk stratification and personalized medication risk score - Google Patents

Population-based medication risk stratification and personalized medication risk score

Info

Publication number
SG11202003873WA
SG11202003873WA SG11202003873WA SG11202003873WA SG11202003873WA SG 11202003873W A SG11202003873W A SG 11202003873WA SG 11202003873W A SG11202003873W A SG 11202003873WA SG 11202003873W A SG11202003873W A SG 11202003873WA SG 11202003873W A SG11202003873W A SG 11202003873WA
Authority
SG
Singapore
Prior art keywords
medication risk
population
personalized
stratification
risk score
Prior art date
Application number
SG11202003873WA
Inventor
Jacques Turgeon
Veronique Michaud
Brian Cicali
Original Assignee
Jacques Turgeon
Veronique Michaud
Brian Cicali
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jacques Turgeon, Veronique Michaud, Brian Cicali filed Critical Jacques Turgeon
Publication of SG11202003873WA publication Critical patent/SG11202003873WA/en

Links

Classifications

    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06QINFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q10/00Administration; Management
    • G06Q10/10Office automation; Time management
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00ICT specially adapted for the handling or processing of medical references
    • G16H70/40ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06QINFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00Information and communication technology [ICT] specially adapted for implementation of business processes of specific business sectors, e.g. utilities or tourism
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Data Mining & Analysis (AREA)
  • Business, Economics & Management (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Databases & Information Systems (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Strategic Management (AREA)
  • Human Resources & Organizations (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Marketing (AREA)
  • Economics (AREA)
  • Entrepreneurship & Innovation (AREA)
  • Tourism & Hospitality (AREA)
  • Physics & Mathematics (AREA)
  • General Business, Economics & Management (AREA)
  • General Physics & Mathematics (AREA)
  • Theoretical Computer Science (AREA)
  • Operations Research (AREA)
  • Quality & Reliability (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
SG11202003873WA 2017-10-31 2018-10-31 Population-based medication risk stratification and personalized medication risk score SG11202003873WA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762579328P 2017-10-31 2017-10-31
US201762611975P 2017-12-29 2017-12-29
PCT/US2018/058405 WO2019089725A1 (en) 2017-10-31 2018-10-31 Population-based medication risk stratification and personalized medication risk score

Publications (1)

Publication Number Publication Date
SG11202003873WA true SG11202003873WA (en) 2020-05-28

Family

ID=66333604

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202003873WA SG11202003873WA (en) 2017-10-31 2018-10-31 Population-based medication risk stratification and personalized medication risk score

Country Status (5)

Country Link
US (2) US20210375486A1 (en)
EP (1) EP3704661A4 (en)
CA (1) CA3080478A1 (en)
SG (1) SG11202003873WA (en)
WO (1) WO2019089725A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021016477A1 (en) * 2019-07-24 2021-01-28 Valisure Llc Evaluation of safety risks
US11694810B2 (en) * 2020-02-12 2023-07-04 MDI Health Technologies Ltd Systems and methods for computing risk of predicted medical outcomes in patients treated with multiple medications
TWI775253B (en) * 2020-12-24 2022-08-21 宏碁股份有限公司 Method for calculating high risk route of administration
CN114242244A (en) * 2021-12-21 2022-03-25 广州海思医疗科技有限公司 Personalized medicine-taking risk prediction and risk stratification system
WO2024009281A1 (en) * 2022-07-07 2024-01-11 Johnson & Johnson Consumer Inc. Method for improving the real-world skin sensitization impact of formulated products

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007116295A2 (en) * 2006-04-07 2007-10-18 Kantonsspital Bruderholz Individual assessment and classification of complex diseases by a data-based clinical disease profile
US8700430B2 (en) * 2006-07-17 2014-04-15 Walgreen Co. Optimization of a medication therapy regimen
US10095836B2 (en) * 2006-09-29 2018-10-09 Gearbox Llc Computational systems for biomedical data
WO2008060287A1 (en) * 2006-11-17 2008-05-22 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Method for determining risk of elderly patient under medical treatment and related systems
US20100223068A1 (en) * 2009-02-27 2010-09-02 Erick Von Schweber Method And Apparatus For The Unified Evaluation, Presentation and Modification of Healthcare Regimens
US8513259B2 (en) * 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
EP2339488A1 (en) * 2009-12-22 2011-06-29 Apteekide Infotehnoloogia OÜ A system for analysis and report of drug interactions
US8744872B1 (en) * 2013-01-03 2014-06-03 Aetna, Inc. System and method for pharmacovigilance
US10210312B2 (en) * 2013-02-03 2019-02-19 Youscript Inc. Systems and methods for quantification and presentation of medical risk arising from unknown factors
US10720241B2 (en) * 2013-12-23 2020-07-21 Tabula Rasa Healthcare, Inc. Medication risk mitigation system and method

Also Published As

Publication number Publication date
US20210375486A1 (en) 2021-12-02
EP3704661A4 (en) 2021-08-04
CA3080478A1 (en) 2019-05-09
WO2019089725A1 (en) 2019-05-09
EP3704661A1 (en) 2020-09-09
US20230019434A1 (en) 2023-01-19

Similar Documents

Publication Publication Date Title
IL290496A (en) Therapeutic antibodies and their uses
HK1256796A1 (en) Bivalent bromodomain inhibitors and uses thereof
IL259530A (en) Shape changing drug delivery devices and methods
GB201519858D0 (en) Therapeutic combinations comprising anti-CD73 antibodies and uses thereof
SG11202003873WA (en) Population-based medication risk stratification and personalized medication risk score
ZA201900209B (en) Novel natural protein and application thereof
HK1252026A1 (en) Pharmaceutical combination and uses thereof
HK1247091A1 (en) Therapeutic antibodies and uses thereof
EP4147246A4 (en) Population-based medication risk stratification and personalized medication risk score
HK1244431A1 (en) Polyaphrons and palpebral administration thereof
LT3299384T (en) Truncated rotavirus vp4 protein and application thereof
IL271073A (en) B4galt1 variants and uses thereof
IL264473A (en) Gpr156 variants and uses thereof
PT3250234T (en) Recombinant mdv1 and the uses thereof
PL3389621T3 (en) Emulsions containig uv-screens and carnosines
ZA201801218B (en) Medicament and nutritional supplement
GB201620702D0 (en) Placement game
GB2542851B (en) Container section and container comprising two container sections
GB201617925D0 (en) Proteins and uses
GB201615812D0 (en) Insulated render and skytrack
GB201522469D0 (en) Word and arithmetic games
AU2015901423A0 (en) Therapeutic antibodies and uses thereof